Report from the AGM of ProfilGruppen AB Around 110

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Apr 10, 2014 at 1:45 PM

Report from the AGM of ProfilGruppen AB

Around 110 shareholders and guests attended today's Annual General Meeting at Folkets Hus in Åseda. The meeting was chaired by Bengt Stillström. The Acting CEO Kåre Wetterberg gave a summary of last year's events and initiatives. Kåre informed about the market for aluminum profiles, both in Europe and Sweden, as well as investments made in the production, and efforts to increase ProfilGruppen's market presence. Finally, he reviewed the financial information regarding last year. Decisions of the Annual General Meeting The income statement and balance sheet as well as the consolidated income statement and the consolidated balance sheet for the 2013 financial year were adopted. Dividend Due to the Group's result the Annual General Meeting decided that no dividend payout shall be made for the financial year of 2013. Election of the Board and auditor The following Board members were reelected; Bengt Stillström, Thomas Widstrand, Mats Egeholm, Susanna Hilleskog and Kåre Wetterberg. Bengt Stillström was elected as Chairman of the Board for the period until a new CEO assumes the position, thereafter it was decided that Kåre Wetterberg returns as Chairman of the Board. The Company’s auditor, Ernst & Young AB, with Johan Thuresson as auditor in charge, was reelected for the period until the close of the 2015 Annual General Meeting. Fees The Annual General Meeting decided on fees for Board members in accordance with the nomination committees proposals. Hence, fees will be paid as follows: To the Chairman SEK 340,000. To other Board members elected in the meeting not employed by the company SEK 125,000 each. The remuneration- and audit committees are included in the Board's tasks and no additional fees will be awarded. No fees will be paid to Board Members and deputies elected by the employees. Remuneration for auditors was decided in accordance with approved invoices. Decision on the nomination committee The Annual General Meeting approved the proposal from the nomination committee on the procedural issues regarding how the new nomination committee is to be appointed and regarding its duties for the Annual General Meeting 2015. Guidelines for remuneration for senior executives The AGM decided on guidelines for remuneration for senior executives according to the proposal of the Board. No essential changes of the principles compared to last year was decided. Minutes from the AGM Verified minutes from the AGM will be published on the Group’s website. Financial information The interim report for the first quarter will be submitted on 23 April 2014. Dates for the release of financial information are available on the Group’s website, www.profilgruppen.se/koncern. Summary of the CEO's speech and verified minutes from the meeting will be published on the company’s website, www.profilgruppen.se/koncern. Åseda, 10 April 2014 Board of ProfilGruppen AB (publ.) Corporate ID no. 556277-8943 _________________________________________ For further information: Kåre Wetterberg, Acting CEO +46 (0)70 656 40 14 Bengt Stillström, Chariman of the Board +46 (0)70 440 40 99 ProfilGruppen is a supplier of customised aluminium extrusions and components. www.profilgruppen.se This information is published in accordance with applicable laws, listing agreements and regulations. The information was submitted for publication at 19.30 CET on April 10, 2014.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Innovent's SINTBILO® Hits Primary Endpoint in Study

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

D-Wave's Legal Trouble: Securities Fraud Suit Looms

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Intelligent Communication Forum Eyes Global Ecosystem Shift

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Top 5 Most Recently Viewed Articles

Old National Bancorp Declares Dividends to Benefit Shareholders

Old National Bancorp Declares Cash Dividends Old National Bancorp, the holding company of Old National Bank, has recently made an important announcement regarding its quarterly dividends. The Board of Directors has officially declared a cash dividend of $0.14 per share on the Company’s outstanding shares of common stock. This move underlines the company’s commitment...

Revolutionary Portable Target Board Streamlines Axe Throwing Fun

Innovative Design for Axe Throwing Enthusiasts A new invention is transforming the world of axe throwing. A creative inventor sought to develop a robust solution for supporting heavy wooden targets. With this ambition in mind, he has introduced the AXXMAN BOARD, which enhances the experience of axe throwing while also ensuring safety and stability. This product aims to...

AI Innovations Transforming Automotive Lighting Market Growth The global automotive lighting market is poised for remarkable growth, with an expected increase of approximately USD 12.38 billion between 2024 and 2028. This growth is largely driven by the rising demand for advanced interior lighting systems, particularly in passenger and commercial vehicles. The advent of...

Wolverine World Wide Insider Purchase Signals Optimism In a recent filing, it has come to light that DeMonty Price, a board member of Wolverine World Wide (NYSE:WWW), made a significant insider purchase, affirming confidence in the future of the company. Details of the Transaction On a recent date, Price purchased 25,000 shares of Wolverine World Wide. This strategic move...

Saigon Technology's Impact on Vietnam's Global Innovation Scene Saigon Technology is making waves in the tech world, showcasing Vietnam's potential as a vibrant hub for global innovation. This remarkable company has recently achieved significant milestones that solidify its position in the industry. With its unyielding commitment to excellence, Saigon Technology has...